General Biologicals Corporation (TPEX: 4117)
Health Care · Biotechnology · TW
NT$8.61
-8.31% today · -42.6% 1Y
General Biologicals Corporation (TPEX: 4117) operates in the Biotechnology industry within the Health Care sector. The company is valued at $18.79M and employs 200 people.
Over the last twelve months the share price has lost 42.6%, trading between 3.50 and 17.30.
Tweenvest scores General Biologicals Corporation across four factors: quality 48/100, value 51/100, growth 0/100. Its strongest factor is value.
4117 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $18.79M
- Revenue (TTM)
- $8.18M
- P/E
- 1.13
- EPS
- 7.64
- Dividend yield
- —
- Beta (5Y)
- 0.58
- 52-week high
- NT$17.30
- 52-week low
- NT$3.50
- Avg volume (3M)
- —
- Shares outstanding
- 70.79M
- Employees
- 200
- Next earnings
- —
About General Biologicals Corporation
General Biologicals Corporation (GBC) is a company dedicated to the research, development, production, and global commercialization of in-vitro diagnostic (IVD) solutions, operating extensively both within Taiwan and internationally. The company's core diagnostic offerings include advanced ELISA and chemiluminescence immunoassays, molecular and cellular diagnostic platforms, and rapid point-of-care testing (POCT) systems. Its diverse portfolio further encompasses COVID-19 related solutions, digital pathology, and contract development manufacturing organization (CDMO) services. Additionally, GBC provides essential blood screening services for detecting hepatitis and HIV, alongside crucial biomaterials such as antibody preparations and human plasma. Venturing beyond diagnostics, the company also markets a line of oral care products under its proprietary 'oh care' brand. These diagnostic systems are primarily utilized by clinics and laboratories. Founded in 1973, General Biologicals Corporation is headquartered in Hsinchu City, Taiwan.
- ISIN
- TW0004117007
- Founded
- 1984
- Listed since
- Oct 25, 2007
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Inhibitor Therapeutics, Inc.OTCPK: INTI | $19.10M | $0.11 | +12.14% |
| GenSight Biologics S.A.ENXTPA: SIGHT | $19.05M | €0.07 | -5.00% |
| HST Global, Inc.OTCPK: HSTC | $18.91M | $0.13 | -80.90% |
| Dextech Medical ABXSAT: DEX | $18.89M | Skr— | — |
| Quoin Pharmaceuticals, Ltd.NasdaqCM: QNRX | $18.74M | $3.90 | -13.33% |
| Estrella Immunopharma, Inc.NasdaqCM: ESLA | $18.70M | $0.43 | +4.88% |
| Akari Therapeutics, PlcNasdaqCM: AKTX | $18.69M | $8.18 | -6.73% |
| Kyntra Bio, Inc.NasdaqGS: KYNB | $18.55M | $4.58 | -12.26% |
Figures last refreshed Oct 18, 2026.